Tissue microarray (TMA) use in post mortem neuropathology. 2021

L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Midlothian, EH25 9RG, UK. Electronic address: liam.wilson@ed.ac.uk.

Tissue microarrays (TMAs), where each block (and thus section) contains multiple tissue cores from multiple blocks potentially allow more efficient use of tissue, reagents and time in neuropathology. The relationship between data from TMA cores and whole sections was investigated using 'virtual' TMA cores. This involved quantitative assessments of microglial pathology in white matter lesions and motor neuron disease, alongside qualitative TDP-43 inclusion status in motor neuron disease cases. Following this, a protocol was developed for TMA construction. For microglial pathology we found good concordance between virtual cores and whole sections for volume density using one 1.75 mm core (equivalent to a 2 mm core after accounting for peripheral tissue loss). More sophisticated microglial cell size and measures required two cores. Qualitative results of pTDP-43 pathology showed use of one 1.75 mm core gave a 100 % sensitivity and specificity within grey matter, and 88.3 % sensitivity and 100 % specificity within white matter. A method of producing the TMAs was suitable for immunohistochemistry both manually and by autostainer, with the minimal core loss from the microscope slide. TMAs have been used infrequently in post mortem neuropathology research. However, we believe TMAs give comparable tissue assessment results and can be constructed, sectioned and stained with relative ease. We found TMAs could be used to assess both quantitative (microglial pathology) and qualitative pathology (TDP-43 proteinopathy) with greatly reduced quantities of tissue, time and reagents. These could be used for further work to improve data acquisition efficiency.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D000069338 Neuropathology The branch of medicine and biomedical science concerned with diseases of the nervous system. Neuropathologists,Neuropathologies,Neuropathologist
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D046888 Tissue Array Analysis The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips. Cell Array Analysis,Cell Microarray Analysis,Tissue Microarray Analysis,Analyses, Cell Array,Analyses, Cell Microarray,Analyses, Tissue Array,Analyses, Tissue Microarray,Analysis, Cell Array,Analysis, Cell Microarray,Analysis, Tissue Array,Analysis, Tissue Microarray,Array Analyses, Cell,Array Analyses, Tissue,Array Analysis, Cell,Array Analysis, Tissue,Cell Array Analyses,Cell Microarray Analyses,Microarray Analyses, Cell,Microarray Analyses, Tissue,Microarray Analysis, Cell,Microarray Analysis, Tissue,Tissue Array Analyses,Tissue Microarray Analyses

Related Publications

L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
February 1977, Lancet (London, England),
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
August 2005, Brain research. Molecular brain research,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
October 2003, Expert reviews in molecular medicine,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
July 2001, Brain research bulletin,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
January 2018, Brain : a journal of neurology,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
January 1978, Medicine, science, and the law,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
November 2017, Journal of law and medicine,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
February 2014, Pathology, research and practice,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
August 2009, Orvosi hetilap,
L A Wilson, and L Heraty, and B A Ashford, and S Coelho, and A F Frangi, and J M Pozo, and P G Ince, and J R Highley
January 2010, Disease markers,
Copied contents to your clipboard!